Voir en Français
Bekijk in het Nederlands

We are evaluating a new PCR test that could be ready in 15 minutes. 

Take part in this study to make it a reality.

miDiagnostics is developing an ultra-fast COVID-19 PCR test to check if it can deliver a reliable result in 15 minutes saving you both time and inconvenience.

Our COVID-19 test is not yet commercially available.
This study S65972 has been approved by the Research Ethics Committee UZ/KU Leuven.

We will use one additional deep nasal swab to compare this new diagnostic method with the current diagnostic practice.

We will also be investigating if an ultra-fast COVID-19 PCR test can be based on exhaled breath.

About the study

  • Participation is voluntary.
  • You will not be charged for any specific actions taken as part of this study.
  • The data collected as part of your participation are confidential. Your anonymity will be assured when the results are published.
  • Before you agree to participate in this study, we ask you to familiarize yourself with what this study will entail so that you can make an informed decision.

The study compares a pre-existing PCR test for determining COVID-19 virus infection and the miDiagnostics ultra-fast PCR test.

Participation

You must be 18 years old or older.
You are intending to travel by airplane.

Purpose

The study compares a pre-existing PCR test for determining COVID-19 virus infection with the miDiagnostics ultra-fast PCR test.

This study will allow us to better understand how well our rapid PCR test works in a fast-paced test environment, such as the airport. We hope to make this rapid PCR test generally available in the future.

In a next stage of the study, instead of a nasal swab, a breath sample will be taken to investigate further the performance of a breath sample on our Ultra-fast PCR.

What is required?

There are 2 phases in this study. You will participate only in one of the 2 phases.
In the first phase, one additional deep nasal swab will be taken on top of your standard nasal swab collection.
In the second phase, a breath sample will be taken as well as the standard nasal swab collection.
There is no need to make any additional visits.

Compensation

For your participation in the study you will receive a voucher worth €25.

Roles of the collaborators

Brussels Airport
Study site.

Eurofins
Analysis of the reference PCR-test, and input on the workflow/data analysis (they will basically shadow us while performing the tests).

Ecolog
R
ecruitment and swabbing / breath sampling.

Imec
PCR reader and breath sampler based on imec technology.

Key Benefits

Innovation

Silicon chip technology allowing for ultra-fast PCR

Quality

Built-in controls ensure the highest quality result

Speed

<15 minutes turnaround time

Sensitivity

Proven sensitivity equal to reference lab-based PCR

 

Specificity

PCR designs cover variants of concern

Scalability

Both testcard (disposable) and reader are highly scalable

Versatility

Easy menu expansion for other infectious diseases (e.g. Flu, RSV)

Workflow

Optimized to reduce hands-on time and enabling high throughput

For participation in the study, please download the Informed Consent Forms.

Please contact a steward at the airport to receive a flyer in your language of preference.

English
French
Dutch
Explore